期刊文献+

The Effect of Different Interventional Treatment on P-Glycoprotein in Different Histopathological Types and Grades of Primary Hepatocellular Carcinoma 被引量:1

The Effect of Different Interventional Treatment on P-Glycoprotein in Different Histopathological Types and Grades of Primary Hepatocellular Carcinoma
下载PDF
导出
摘要 To study the effect of the different interventional treatment on P Glycoprotein (Pgp) in different histopathological types of primary hepatocellular carcinoma (PHC), 98 surgically and histologically verified PHC specimens were obtained. The patients included 57 patients treated by surgical resection alone and 41 patients receiving second stage surgical resection after four kinds of interventional treatment. SABC immunohistochemical staining with a monoclonal antibody against human Pgp was used to observe the Pgp in all specimens. The positive rate of Pgp was 100 % in group of chemotherapy alone ( P <0.05), 62.5 % in group of chemotherapy combined with iodized oil ( P >0.05), 46.6 % in group of chemotherapy combined with iodized oil and spongia gelatini absorbens (Sga) ( P >0.05), 18.18 % in group of chemotherapy combined with Ethanol iodized oil and Sga ( P <0.05) and 52.63 % in group of surgical resection alone. The positive rate of Pgp varied with different histopathological types, with rate of clear cell PHC being the lowest, and that of poorly differentiated or undifferentiated PHC the highest. The positive rate of Pgp was increased as pathological grades increased. Overexpression of Pgp may be responsible for the intrinsic and acquired drug resistance of PHC. Multidrug resistance (MDR) varied with different histological types. Therapy of PHC should be tailored according to individual. Local chemotherapy combined with ethanol iodized oil and Sga embolization may become a new way to overcome MDR of PHC. To study the effect of the different interventional treatment on P Glycoprotein (Pgp) in different histopathological types of primary hepatocellular carcinoma (PHC), 98 surgically and histologically verified PHC specimens were obtained. The patients included 57 patients treated by surgical resection alone and 41 patients receiving second stage surgical resection after four kinds of interventional treatment. SABC immunohistochemical staining with a monoclonal antibody against human Pgp was used to observe the Pgp in all specimens. The positive rate of Pgp was 100 % in group of chemotherapy alone ( P <0.05), 62.5 % in group of chemotherapy combined with iodized oil ( P >0.05), 46.6 % in group of chemotherapy combined with iodized oil and spongia gelatini absorbens (Sga) ( P >0.05), 18.18 % in group of chemotherapy combined with Ethanol iodized oil and Sga ( P <0.05) and 52.63 % in group of surgical resection alone. The positive rate of Pgp varied with different histopathological types, with rate of clear cell PHC being the lowest, and that of poorly differentiated or undifferentiated PHC the highest. The positive rate of Pgp was increased as pathological grades increased. Overexpression of Pgp may be responsible for the intrinsic and acquired drug resistance of PHC. Multidrug resistance (MDR) varied with different histological types. Therapy of PHC should be tailored according to individual. Local chemotherapy combined with ethanol iodized oil and Sga embolization may become a new way to overcome MDR of PHC.
出处 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2000年第3期231-234,共4页 华中科技大学学报(医学英德文版)
基金 This project was supported by a grand from National re-search project foundation of China(No.96 - 90 7- 0 3- 0 1)
关键词 hepatocellular carcinoma interventional radiology P glycoprotein gene expression IMMUNOHISTOCHEMISTY hepatocellular carcinoma interventional radiology P glycoprotein gene expression immunohistochemisty
  • 相关文献

参考文献9

  • 1俞悦,文跃进,郑肇巽.多药耐药基因MDR1在原发性肝癌组织中表达的意义[J].肝胆外科杂志,1998,6(1):56-57. 被引量:8
  • 2王学浩,孔连宝,杜竞辉,邢益平,黄祖瑚,李忠佑,王建东.多药耐药基因在人原发性肝细胞癌中的表达[J].普外基础与临床杂志,1996,3(3):129-132. 被引量:4
  • 3den Boer M L,Pielers R,Kazemier K M et al.Relationship between major vault protein lung resistance protein,multidrug resistance-associated protein P-glycoprotein expression and drug resistance in childhood leukaemia. Blood . 1998
  • 4Sharp S Y,Smith V,Hobbs S et al.Lack of a role for MRP1 in platinum drug resistance in human ovarian cancer all lines. British Journal of Cancer . 1998
  • 5Lau A,Nightingale S,Taylor G B et al.Enhanced MDR1 gene expression in human T-cell leukaemia virusI -infected patients offers new prospects for therapy. Blood . 1998
  • 6Boldogy I,Ramana C V,Chen I et al.Regulation of expression of the DNA repair gene 6-methylguanine-DNA methyltransterase via protein kinase C-mediated signaling. Cancer Research . 1998
  • 7Okuda S.Transcatheter arterial embolization for advanced hepatocellular carcinoma: the controversy continues. Hepatology . 1998
  • 8Eid H,Gulyas M,Geczi L et al.Expression of bcl-2 in testicular carcinoma, correlation with tumor progression and MDR1 Pgp. Cancer . 1998
  • 9Lacave R,Coulet F,Ricei S et al.Comparative evaluation by semiquantitative reverse transcriptase polymerase chain reaction of MDR1, MRP, and GST gene expression in breast carcinimas. British Journal of Cancer . 1998

二级参考文献4

共引文献10

同被引文献2

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部